Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vogt-Koyanagi-Harada disease.

Russell W Read1

  • 1Department of Ophthalmology, University of Alabama School of Medicine, University of Alabama at Birmingham, 700 18th Street South, EFH DB110-0009, Birmingham, AL 35233, USA. rwr@uab.edu

Ophthalmology Clinics of North America
|November 19, 2002
PubMed
Summary

Vogt-Koyanagi-Harada disease is a chronic autoimmune condition affecting multiple systems, primarily targeting melanocytes. Early diagnosis and treatment with corticosteroids are crucial for managing this vision-threatening condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anterior scleritis with IgG4 lymphoplasmacytic infiltration: a case report.

Journal of ophthalmic inflammation and infection·2025
Same author

Effectiveness of Frequently Used TNF Inhibitors vs. Conventional Immunosuppressive Therapies for Noninfectious Uveitis.

Ocular immunology and inflammation·2025
Same author

Use of immunosuppression and subsequent cancer incidence: cohort study.

BMJ oncology·2025
Same author

Purtscher-Like Retinopathy and Acute Macular Neuroretinopathy in a Child with Acute Influenza A.

Retina (Philadelphia, Pa.)·2024
Same author

Use of Immunosuppression and the Risk of Subsequent Overall or Cancer Mortality.

Ophthalmology·2023
Same author

Cataracts, Corticosteroids, and Canaries in the Coal Mine.

American journal of ophthalmology·2023

Area of Science:

  • Ophthalmology
  • Immunology
  • Neurology

Background:

  • Vogt-Koyanagi-Harada disease is a rare, chronic, granulomatous systemic autoimmune disorder.
  • It affects ocular, central nervous, auditory, and integumentary systems, with melanocyte antigens as the apparent target.
  • Common in individuals of Asian, Middle Eastern, Native American, and Hispanic ethnicities.

Purpose of the Study:

  • To summarize the key features, presentation, and management of Vogt-Koyanagi-Harada disease.
  • To highlight the importance of early diagnosis and treatment in preventing visual impairment.

Main Methods:

  • Review of existing literature on Vogt-Koyanagi-Harada disease.
  • Analysis of clinical manifestations, diagnostic criteria, and therapeutic approaches.

Main Results:

  • Neurologic symptoms often precede visual decline due to choroiditis and exudative retinal detachments.
  • Corticosteroids are the primary treatment, with other immunosuppressants potentially needed.
  • Potential complications include cataract, glaucoma, choroidal neovascularization, and subretinal fibrosis, impacting visual acuity.

Conclusions:

  • Vogt-Koyanagi-Harada disease requires prompt management, typically with corticosteroids, to mitigate severe visual loss.
  • Awareness of its multi-systemic nature and potential complications is essential for effective patient care.

Related Experiment Videos